Brief: Insilico Medicine Cayman Topco Receives FDA IND Approval For ISM8969
23/01/2026 24:02
Jan 23 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK: RECEIVES FDA IND APPROVAL FOR ISM8969 Further company coverage: 3696.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7